Has FIGS (FIGS) Run Too Far Ahead Of Fair Value?

FIGS (FIGS) has drawn fresh attention after its recent share price move, with the stock up about 46% over the past month and 31% over the past 3 months. That shift is prompting investors to reassess the direct to consumer healthcare apparel company’s current valuation and growth profile.

The recent surge in FIGS shares sits on top of a broader recovery, with a 1 year total shareholder return of 118.72% and a year to date share price return of 35.38%. However, the 5 year total shareholder return of 65.35% reflects earlier weakness that longer term holders will still be weighing against the current momentum.

Compare FIGS’ momentum with other direct to consumer and apparel names by scanning our hand picked list of 19 high quality undiscovered gems, which are also drawing fresh interest from the market.

After a move like this, the question shifts from momentum to math. With FIGS at $15.42, analyst targets and intrinsic value estimates point to a wide spread. The real question is where fair value sits within that range.

Most Popular Narrative: 7.2% Overvalued

FIGS is trading at $15.42, while the most followed narrative on the stock points to a fair value of $14.39. That gap frames the next question for investors, which is how realistic the underlying growth and margin assumptions look.

FIGS concentrates on a specific niche within the healthcare industry: medical professionals. The company sells primary apparel, as well as related products. By catering to the unique needs and preferences of this market segment, FIGS tailors its products to precisely match their requirements. This has allowed the company to develop a brand synonymous with this segment, improving its competitive positioning.

Read the complete narrative.

Want to understand why this narrative comes out above the current price? It leans on continued revenue growth, firmer margins and a premium future earnings multiple. The precise mix of these inputs matters. The full narrative lays out exactly how they combine to reach that $14.39 fair value.

Result: Fair Value of $14.39 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, this FIGS narrative still carries real risk if revenue slows further or margin progress stalls, which could quickly challenge the current fair value assumptions.

Find out about the key risks to this FIGS narrative.

Next Steps

With FIGS sparking strong views on both value and risk, now is a good time to look through the numbers yourself and pressure test the potential upside. To see what investors are optimistic about, review the 3 key rewards.

Looking for more FIGS style investment ideas?

If FIGS has sharpened your interest, do not stop here. Fresh ideas from different corners of the market can round out your watchlist and highlight opportunities you might otherwise miss.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include FIGS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com